謝鎮陽 (Cheng-Yang Hsieh) (@chengyanghsieh) 's Twitter Profile
謝鎮陽 (Cheng-Yang Hsieh)

@chengyanghsieh

Cheng-Yang Hsieh, MD, PhD

Stroke neurologist, @WorldStrokeOrg B&H Task Force, big data research, father of 2 teenagers and 1 cat, and a baseball fan

ID: 984638665207906304

linkhttps://cheng-yang-hsieh.blogspot.com/ calendar_today13-04-2018 03:45:26

1,1K Tweet

737 Followers

1,1K Following

Dr. Negar Asdaghi (@nasdaghi) 's Twitter Profile Photo

A must read. The growing evidence in support of factor XI inhibitors. Head to head comparison of Abelacimab versus Rivaroxaban in high risk Afib shows better safety profile in favor of Abelacimab. Once a month injection vs daily DOAC ⁦NEJM⁩ nejm.org/doi/full/10.10…

Stephan A Mayer (@stephanamayer) 's Twitter Profile Photo

Until reading this review I have to admit I never understood the point of non-inferiority trials. The point is to test a new treatment that has a clear advantage over the established control in terms of cost, convenience, toxicity or safety. ahajournals.org/doi/abs/10.116…

謝鎮陽 (Cheng-Yang Hsieh) (@chengyanghsieh) 's Twitter Profile Photo

"The #Chinese are bravest when safe, cowardly when in danger; bullies to the weak, servile to the strong; fierce to the kind, and eerily silent before evil." — Lin Yutang

Antony Chen (@antonyneuro) 's Twitter Profile Photo

Check out our latest work on Stroke AHA/ASA showing that MRI-detected hemorrhagic transformation (HI1 & HI2) does NOT lead to worse outcomes. Great opportunity to work with Ashkan Shoamanesh Eric_Smith_VCI again! ahajournals.org/doi/10.1161/ST…

World Stroke Academy (@worldstrokeed) 's Twitter Profile Photo

We had to jump on the trend: World Stroke Academy 3D figure✨ Our cartoon doll is a proud registered learner, regular participant in our webinars, eLearning modules & more! She represents the fun & creative side of our mission to deliver #StrokeEducation worldwide💻🌍 (AI-generated)

We had to jump on the trend: <a href="/WorldStrokeEd/">World Stroke Academy</a> 3D figure✨ 

Our cartoon doll is a proud registered learner, regular participant in our webinars, eLearning modules &amp; more! She represents the fun &amp; creative side of our mission to deliver #StrokeEducation worldwide💻🌍

(AI-generated)
David Seiffge (@davidseiffge) 's Twitter Profile Photo

LAAO and stroke: We summarize current evidence & ongoing trials: promising option for AF patients to avoid OAC (i.e. after ICH, CAA) or if DOAC alone is not enough (i.e. after #breakthroughstroke) Alexander BenzELAPSE⁩ ⁦Stroke AHA/ASA⁩ ahajournals.org/doi/10.1161/ST…

Stroke AHA/ASA (@strokeaha_asa) 's Twitter Profile Photo

#STROKE: This topical review by Vu et al. critically appraises the literature surrounding 4 commonly-encountered scenarios in stroke secondary prevention and offers considerations for practice. Shravan Sivakumar @brainwithn #AHAJournals ahajrnls.org/3GnHoI6

#STROKE: This topical review by Vu et al. critically appraises the literature surrounding 4 commonly-encountered scenarios in stroke secondary prevention and offers considerations for practice. <a href="/sshravanMD/">Shravan Sivakumar</a> @brainwithn #AHAJournals ahajrnls.org/3GnHoI6
Benjamin Tan (@drbenjamintan) 's Twitter Profile Photo

Our study in International Journal of Stroke shows young adults face significant stroke recurrence risks: 4.5-7.3% recurrence rate within just 1 year, increasing to 10.5-12.8% at 5 years and 14.0-20.3% beyond 10 years. Teddy Wu leonard yeo Ching-Hui SIA #YoungStroke doi.org/10.1177/174749…

Our study in <a href="/IntJStroke/">International Journal of Stroke</a> shows young adults face significant stroke recurrence risks: 4.5-7.3% recurrence rate within just 1 year, increasing to 10.5-12.8% at 5 years and 14.0-20.3% beyond 10 years.
<a href="/Teddyyhwu/">Teddy Wu</a> <a href="/leonardyeo1/">leonard yeo</a> <a href="/chinghuisia/">Ching-Hui SIA</a> 

#YoungStroke

doi.org/10.1177/174749…
Seemant Chaturvedi (@chaturvedineuro) 's Twitter Profile Photo

From the ECST 2 authors: "The results support treating patients with asymptomatic and low or intermediate risk symptomatic carotid stenosis with OMT alone until further data from the 5-year analysis of ECST-2 and other trials become available". The Lancet Neurology European Stroke Org

Amit Chaudhari MD (@neuroirdoc) 's Twitter Profile Photo

6 clinical trials. Level 1A recommendations. Are there really any doubts left.. SVIN #missionthrombectomy #worldthrombectomyday #strokeawarenessmonth

6 clinical trials. Level 1A recommendations. Are there really any doubts left.. 

<a href="/svinsociety/">SVIN</a>
#missionthrombectomy
#worldthrombectomyday
#strokeawarenessmonth
Stroke AHA/ASA (@strokeaha_asa) 's Twitter Profile Photo

#STROKE Images: Endovascular OCT provides confirmation at a near-pathological level intraplaque hemorrhage. 🟠 #AHAJournals ahajrnls.org/3Zo6e19

#STROKE Images: Endovascular OCT provides confirmation at a near-pathological level intraplaque hemorrhage. 🟠 #AHAJournals ahajrnls.org/3Zo6e19
Beom Joon [BJ] Kim (@kimbjstroke) 's Twitter Profile Photo

Now we can teach machines by machines. Segmentation of leukoaraiosis on NCCT by MRI without human annotations, worked with Jae Song onlinelibrary.wiley.com/doi/10.1002/br…

Now we can teach machines by machines. 
Segmentation of leukoaraiosis on NCCT by MRI without human annotations, worked with <a href="/jsongmd/">Jae Song</a> 

onlinelibrary.wiley.com/doi/10.1002/br…
Luciano Sposato 🇦🇷🇨🇦 (@sposatol) 's Twitter Profile Photo

Nice paper by Christian H Nolte Jan Scheitz 🧠⚡️❤️ et al. from CSB Charité - Universitätsmedizin Berlin ✅ Background. Troponin elevation is common post-stroke, but mechanisms remain unclear 🧠 Population. 508 ischemic stroke patients with serial hs-cTnT in 1st 48h – 254 with acute myocardial